DR. MANISH JAIN (M.D.) – Rheumatology Physician, NPI 1417075581
Rheumatology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
357 RHEUMATOLOGY in IL
Provider Addresses for DR. MANISH JAIN (M.D.)
2845 N Sheridan Rd
Suite 6400
Chicago, IL 60657
Phone: (773) 665-8400
Type: Location
2845 N SHERIDAN RD
SUITE 6400
CHICAGO, IL 60657
Phone: (773) 665-8400
Type: Location
800 Austin St
Suite 208
Evanston, IL 602023439
Phone: (847) 866-8988
Fax: (847) 866-8990
Type: Location
800 AUSTIN ST
SUITE 208
EVANSTON, IL 602023439
Phone: (847) 866-8988
Fax: (847) 866-8990
Type: Mailing
1945 W WILSON AVE STE 100
CHICAGO, IL 606407927
Phone: (773) 769-9040
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 742 Open Payments records for all available years, with a total value of $642,847.
Total Amount is formed as General ($560,882) + Research ($81,965) + Ownership ($0) = $642,847.
Last reported payment date: 2024-12-18 • Largest payer in this snapshot: ABBVIE INC. ($255,238).
Total Amount
$642,847
General + Research + Ownership
Payments
742
Total payment records
General Amount
$560,882
General payments
Research Amount
$81,965
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-18
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| ABBVIE INC. | $255,238 |
| Amgen Inc. | $102,826 |
| Eli Lilly and Company | $81,965 |
| Lilly USA, LLC | $61,157 |
| Janssen Biotech, Inc. | $57,707 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2012-10-01
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20121001000144 | I | Rheumatology | IL | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 14,352 | 23 | $0 |
| J0897 | Injection, denosumab, 1 mg | 2,760 | 28 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 542 | 238 | $0 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 195 | 37 | $0 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 146 | 11 | $0 |
Insurance plans in this area (ZIP 60657)
Loading plans...
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.